Logo image of ALHC

ALIGNMENT HEALTHCARE INC (ALHC) Stock Fundamental Analysis

NASDAQ:ALHC - Nasdaq - US01625V1044 - Common Stock - Currency: USD

15.22  -0.27 (-1.74%)

After market: 14.98 -0.24 (-1.58%)

Fundamental Rating

2

ALHC gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 109 industry peers in the Health Care Providers & Services industry. ALHC has a bad profitability rating. Also its financial health evaluation is rather negative. ALHC is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year ALHC has reported negative net income.
In the past year ALHC has reported a negative cash flow from operations.
ALHC had negative earnings in each of the past 5 years.
In multiple years ALHC reported negative operating cash flow during the last 5 years.
ALHC Yearly Net Income VS EBIT VS OCF VS FCFALHC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 0 -50M -100M -150M

1.2 Ratios

ALHC has a Return On Assets of -20.82%. This is in the lower half of the industry: ALHC underperforms 79.63% of its industry peers.
ALHC's Return On Equity of -125.84% is on the low side compared to the rest of the industry. ALHC is outperformed by 80.56% of its industry peers.
Industry RankSector Rank
ROA -20.82%
ROE -125.84%
ROIC N/A
ROA(3y)-26.52%
ROA(5y)-21.89%
ROE(3y)-73.64%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALHC Yearly ROA, ROE, ROICALHC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 0 50 -50

1.3 Margins

The Gross Margin of ALHC (10.45%) is worse than 76.85% of its industry peers.
In the last couple of years the Gross Margin of ALHC has declined.
The Profit Margin and Operating Margin are not available for ALHC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 10.45%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.99%
GM growth 5YN/A
ALHC Yearly Profit, Operating, Gross MarginsALHC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 10 -10

More info and screens

3

2. Health

2.1 Basic Checks

ALHC does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ALHC has more shares outstanding
ALHC has a worse debt/assets ratio than last year.
ALHC Yearly Shares OutstandingALHC Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 50M 100M 150M
ALHC Yearly Total Debt VS Total AssetsALHC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 200M 400M 600M

2.2 Solvency

An Altman-Z score of 4.47 indicates that ALHC is not in any danger for bankruptcy at the moment.
ALHC has a better Altman-Z score (4.47) than 82.41% of its industry peers.
ALHC has a Debt/Equity ratio of 1.84. This is a high value indicating a heavy dependency on external financing.
ALHC's Debt to Equity ratio of 1.84 is on the low side compared to the rest of the industry. ALHC is outperformed by 75.93% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.84
Debt/FCF N/A
Altman-Z 4.47
ROIC/WACCN/A
WACC9.18%
ALHC Yearly LT Debt VS Equity VS FCFALHC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 100M 200M 300M

2.3 Liquidity

A Current Ratio of 1.60 indicates that ALHC should not have too much problems paying its short term obligations.
ALHC has a better Current ratio (1.60) than 60.19% of its industry peers.
ALHC has a Quick Ratio of 1.60. This is a normal value and indicates that ALHC is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.60, ALHC is in the better half of the industry, outperforming 62.04% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.6
Quick Ratio 1.6
ALHC Yearly Current Assets VS Current LiabilitesALHC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 100M 200M 300M 400M 500M

More info and screens

7

3. Growth

3.1 Past

ALHC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 8.33%, which is quite good.
Looking at the last year, ALHC shows a very strong growth in Revenue. The Revenue has grown by 43.46%.
Measured over the past years, ALHC shows a very strong growth in Revenue. The Revenue has been growing by 23.88% on average per year.
EPS 1Y (TTM)8.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%22.22%
Revenue 1Y (TTM)43.46%
Revenue growth 3Y23.88%
Revenue growth 5YN/A
Sales Q2Q%51.61%

3.2 Future

The Earnings Per Share is expected to grow by 20.71% on average over the next years. This is a very strong growth
Based on estimates for the next years, ALHC will show a very strong growth in Revenue. The Revenue will grow by 28.19% on average per year.
EPS Next Y10.55%
EPS Next 2Y15.91%
EPS Next 3Y14.01%
EPS Next 5Y20.71%
Revenue Next Year48.45%
Revenue Next 2Y38.86%
Revenue Next 3Y33.41%
Revenue Next 5Y28.19%

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
ALHC Yearly Revenue VS EstimatesALHC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2B 4B 6B
ALHC Yearly EPS VS EstimatesALHC Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 -0.5 -1

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

ALHC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ALHC. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALHC Price Earnings VS Forward Price EarningsALHC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALHC Per share dataALHC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

ALHC's earnings are expected to grow with 14.01% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y15.91%
EPS Next 3Y14.01%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALHC!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ALIGNMENT HEALTHCARE INC

NASDAQ:ALHC (1/28/2025, 8:22:20 PM)

After market: 14.98 -0.24 (-1.58%)

15.22

-0.27 (-1.74%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)10-29 2024-10-29/amc
Earnings (Next)N/A N/A
Inst Owners46.93%
Inst Owner Change-0.07%
Ins Owners4.34%
Ins Owner Change-3.72%
Market Cap2.92B
Analysts83.16
Price Target13.54 (-11.04%)
Short Float %8.8%
Short Ratio4.81
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.42%
Min EPS beat(2)3.21%
Max EPS beat(2)11.63%
EPS beat(4)2
Avg EPS beat(4)-1.38%
Min EPS beat(4)-10.3%
Max EPS beat(4)11.63%
EPS beat(8)5
Avg EPS beat(8)6.39%
EPS beat(12)9
Avg EPS beat(12)13.36%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)3.64%
Min Revenue beat(2)2.53%
Max Revenue beat(2)4.75%
Revenue beat(4)4
Avg Revenue beat(4)3.36%
Min Revenue beat(4)2.53%
Max Revenue beat(4)4.75%
Revenue beat(8)7
Avg Revenue beat(8)2.66%
Revenue beat(12)11
Avg Revenue beat(12)3.66%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.82%
PT rev (3m)28.24%
EPS NQ rev (1m)0%
EPS NQ rev (3m)1.89%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.8%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)7.05%
Revenue NY rev (1m)0.15%
Revenue NY rev (3m)1.75%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.18
P/FCF N/A
P/OCF N/A
P/B 25.47
P/tB 38.81
EV/EBITDA N/A
EPS(TTM)-0.77
EYN/A
EPS(NY)-0.51
Fwd EYN/A
FCF(TTM)-0.97
FCFYN/A
OCF(TTM)-0.75
OCFYN/A
SpS12.87
BVpS0.6
TBVpS0.39
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -20.82%
ROE -125.84%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 10.45%
FCFM N/A
ROA(3y)-26.52%
ROA(5y)-21.89%
ROE(3y)-73.64%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.99%
GM growth 5YN/A
F-Score2
Asset Turnover3.56
Health
Industry RankSector Rank
Debt/Equity 1.84
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 163.57%
Cap/Sales 1.73%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.6
Quick Ratio 1.6
Altman-Z 4.47
F-Score2
WACC9.18%
ROIC/WACCN/A
Cap/Depr(3y)141.79%
Cap/Depr(5y)117.76%
Cap/Sales(3y)1.77%
Cap/Sales(5y)1.66%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)8.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%22.22%
EPS Next Y10.55%
EPS Next 2Y15.91%
EPS Next 3Y14.01%
EPS Next 5Y20.71%
Revenue 1Y (TTM)43.46%
Revenue growth 3Y23.88%
Revenue growth 5YN/A
Sales Q2Q%51.61%
Revenue Next Year48.45%
Revenue Next 2Y38.86%
Revenue Next 3Y33.41%
Revenue Next 5Y28.19%
EBIT growth 1Y12.44%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year97.15%
EBIT Next 3Y40.11%
EBIT Next 5Y33.32%
FCF growth 1Y-450.35%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-295.66%
OCF growth 3YN/A
OCF growth 5YN/A